Expression of copeptin and midkine in diabetic retinopathy and their significance
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [12]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To investigate the expression of copeptin and midkine(MK)in patients with diabetic retinopathy and their clinical significance.

    METHODS: Totally 180 patients with type 2 diabetes mellitus(T2DM)admitted to our hospital from June 2016 to October 2017 were divided into three groups according to the criteria of diabetic retinopathy staging. Among them, there were no retinopathy group(68 cases), non-proliferative retinopathy group(72 cases), proliferative retinopathy group(40 cases)and 90 healthy subjects in the same period as the control group. The copeptin level was detected by double antibody immunosorbent assay and the MK level by ELISA. The glycosylated hemoglobin(HbA1c)was detected by TOSOH automatic glycosylated hemoglobin analyzer and the whole blood hs-CRP was detected by using blood routine instrument. Fasting plasma glucose(FPG), triglyceride(TG), cholesterol(TC), low density lipoprotein(LDL-C)and high density lipoprotein(HDL-C)were detected by automatic biochemical analyzer and the systolic blood pressure(SBP)and diastolic blood pressure(DBP)of each group were recorded. The relationship between copeptin and MK levels and blood lipid, blood pressure, biochemical parameters and the course of diabetes mellitus were also analyzed.

    RESULTS: The levels of copeptin and MK in patients with diabetic retinopathy were significantly higher than those in controls, and the levels of copeptin and MK were gradually increased with the progress of disease(P<0.05). The levels of copeptin and MK were correlated with the levels of HbA1c, hs-CRP and course of T2DM(P<0.05), but no significant correlation with plasma lipids, blood pressure and FPG(all P>0.05).

    CONCLUSION: The copeptin and MK levels are closely related to the course of diabetic retinopathy and the severity of the disease, both of which may be involved in the development of diabetic retinopathy.

    Reference
    1杨宇,田敏,吕红彬. 糖尿病视网膜病变的治疗进展. 眼科新进展 2015; 35(5):497-500
    2张凤俊,易敬林,李晶明,等. 糖尿病视网膜病变发病机制研究进展. 眼科新进展 2016; 36(6):584-587
    3郝海荣,张勇,程亮,等. 血清和肽素对2型糖尿病肾功能损害的诊断及预后判断的临床意义. 安徽医药 2016; 20(1):106-109
    4毛艳梅,金学林. 和肽素和糖化血红蛋白水平在2型糖尿病合并急性冠脉综合征患者中的作用研究. 宁夏医学杂志 2016; 38(12):1157-1158
    5徐清田,马宁,成兴波. 血清中期因子水平与糖尿病视网膜病变的相关性研究. 中国糖尿病杂志 2015; 23(11):991-994
    6黄玉庚,孙亮亮,刘海波. 糖尿病视网膜病变程度与颈动脉内-中膜厚度的相关性研究. 健康研究 2015; 35(2):177-178
    7陈淑惠,孟倩丽,张敏,等. 2型糖尿病视网膜病变与糖尿病其他并发症的相关性. 国际眼科杂志 2016; 16(2):309-312
    8罗萍,毛继明,汪浩,等. 相关生物标志物在糖尿病肾病早期诊断的临床意义. 检验医学与临床 2017; 14(14):2082-2085
    9阳慧,苏雨江. 和肽素与高血压的研究. 中国心血管病研究 2015; 13(8):685-688
    10冯光勇,黄伟,任红苗. 血浆和肽素水平对糖尿病视网膜病变的诊断价值. 山东医药 2017; 57(20):76-78
    11周纯,牛佳媛,蔡洁,等. 糖尿病视网膜病变细胞因子及视网膜血流变化的意义. 国际眼科杂志 2015; 15(6):1030-1032
    12陈家欣,林如海. 血清中期因子联合总胆红素在糖尿病视网膜病变中的诊断价值. 中国糖尿病杂志 2017; 25(2):121-124
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Jian-Dan Ren, Jun Zhou. ,/et al.Expression of copeptin and midkine in diabetic retinopathy and their significance. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(11):2085-2087

Copy
Share
Article Metrics
  • Abstract:1033
  • PDF: 1042
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:March 08,2018
  • Revised:September 25,2018
  • Online: October 22,2018